U.S. Markets close in 1 hr 23 mins

A Look at GSK’s Spending and Earnings in Fiscal 2019

Margaret Patrick
A Look at GSK’s Spending and Earnings in Fiscal 2019

In the first-quarter earnings investor presentation, GlaxoSmithKline (GSK) reaffirmed adjusted EPS guidance of a YoY decline of 5%–9% YoY in fiscal 2019.